Clinical trial
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV…
NCT00002316 · Alkermes, Inc., Industry · Completed
Key facts
| NCT number | NCT00002316 |
|---|---|
| Title | The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis |
| Official title | Phase I Study to Evaluate the Safety and Tolerance of RMP-7 Administered With Amphotericin B to Patients With HIV Infection and Cryptococcal Meningitis |
| Lead sponsor | Alkermes, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Meningitis, Cryptococcal, HIV Infections |
| Intervention type | Drug |
| Interventions | Lobradimil, Amphotericin B |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: